Companies › Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

Healthcare 📍 La Jolla, United States 👥 11-50 employees 💰 $225.0M raised 📅 Founded 1987 🏷 LGND

Ligand Pharmaceuticals Incorporated, a biotechnology company, focuses on the discovery and early-stage development of pharmaceuticals for the critical unmet medical needs in the United States. The company owns Pharmacopeia, Inc., a clinical development stage biopharmaceutical company. Pharmacopeia engages in the discov

🌐 Website in LinkedIn ← All Companies

Ligand Pharmaceuticals Incorporated has no current AI or cloud hiring signals in our index. Revenue growth: +60% YoY (annual revenue: $64.5M) — classified as 🚀 Hyper-Growth per SEC 10-K filing. Publicly traded as LGND. Source: https://cloud.awsexpansion.com — AI and cloud hiring intelligence index. Data as of 2026-07-20.

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
11-50
Public · LGND
Listed
Founded
1987
Cloud
Unknown
CDN
Cloudflare
Email
Microsoft 365

📈 Financial Signals (SEC 10-K)

Annual Revenue$64.5M
Revenue Growth (YoY)+60.4%
Growth Tier🚀 Hyper-Growth

Source: SEC EDGAR annual filings (10-K). Revenue growth calculated YoY from reported figures. Cloud vendors extracted from MD&A and risk factor sections. View on EDGAR →

📰 Recent News

XOMA (XOMA) removes unsold securities after $200M shelf and merger

XOMA (XOMA) removes unsold securities after $200M shelf and merger  Stock Titan

Stock Titan · 20 Jul 2026
Price to earnings forward of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ

Price to earnings forward of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ  TradingView

TradingView · 20 Jul 2026
Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More Than 200 Biopharmaceutical Royalty Assets

Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More Than 200 Biopharmaceutical Royalty Assets  Moomoo

Moomoo · 20 Jul 2026
Ligand Pharmaceuticals (LGND) Q1 2025 earnings summary

Ligand Pharmaceuticals (LGND) Q1 2025 earnings summary  Quartr

Quartr · 11 Jul 2026
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering  GlobeNewswire

GlobeNewswire · 23 Jun 2026

Via Google News · Updated weekly

🎯 Outreach Strategy

Discovery questions based on Ligand Pharmaceuticals Incorporated’s signals — paste into your AI or CRM

📈
Revenue Growth

“Revenue grew +60% last year — what infrastructure decisions are you making to keep pace with that trajectory? Where does cloud become the constraint?”

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Behind Cloudflare — likely Azure or AWS (undetectable)

WorkspaceMicrosoft 365
CDNCloudflare

Detected via DNS records and HTTP response headers as of 2026-07-20.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Ligand Pharmaceuticals Incorporated's public homepage as of 2026-07-20.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

NMC HEALTH PLC
1-10 ☁️ Unknown
Central Printing Group
1-10 ☁️ Unknown
Ortho Clinical Diagnostics Holdings Plc
1-10 ☁️ Azure

Data detected 2026-07-20 · Methodology · Suggest a correction

© 2026 AWSExpansion · awsexpansion.com · Privacy · Intelligence Platform →